Author Correction: Hydrophobic pore gates regulate ion permeation in polycystic kidney disease 2 and 2L1 channels.

Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
26 03 2019
Historique:
entrez: 28 3 2019
pubmed: 28 3 2019
medline: 28 3 2019
Statut: epublish

Résumé

The original version of this Article contained an error in the spelling of the author David Bulkley, which was incorrectly given as David Bulkey. This has now been corrected in both the PDF and HTML versions of the Article.

Identifiants

DOI: 10.1038/s41467-019-09422-4 PMID: 30914650 PMC: PMC6435729
pubmed: 30914650
doi: 10.1038/s41467-019-09422-4
pii: 10.1038/s41467-019-09422-4
pmc: PMC6435729
doi:

Types de publication

Journal Article Published Erratum

Langues

eng

Pagination

1452

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK110575
Pays : United States

Commentaires et corrections

Type : ErratumFor

Auteurs

Wang Zheng (W)

National "111" Center for Cellular Regulation and Molecular Pharmaceutics, Hubei University of Technology, Wuhan, Hubei, 430068, China.
Department of Physiology, Membrane Protein Disease Research Group, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, T6G 2H7, Canada.

Xiaoyong Yang (X)

Department of Biochemistry, University of Utah School of Medicine, Salt Lake City, UT, 84112, USA.

Ruikun Hu (R)

School of Life Sciences and Technology, Tongji University, Shanghai, 200092, China.

Ruiqi Cai (R)

Department of Physiology, Membrane Protein Disease Research Group, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, T6G 2H7, Canada.

Laura Hofmann (L)

Experimentelle und Klinische Pharmakologie und Toxikologie, Universität des Saarlandes, Homburg, 66421, Germany.

Zhifei Wang (Z)

Department of Biological Sciences, St. John's University, Queens, NY, 11439, USA.

Qiaolin Hu (Q)

Department of Physiology, Membrane Protein Disease Research Group, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, T6G 2H7, Canada.

Xiong Liu (X)

Department of Physiology, Membrane Protein Disease Research Group, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, T6G 2H7, Canada.

David Bulkley (D)

Keck Advanced Microscopy Laboratory and Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA, 94143, USA.

Yong Yu (Y)

Department of Biological Sciences, St. John's University, Queens, NY, 11439, USA.

Jingfeng Tang (J)

National "111" Center for Cellular Regulation and Molecular Pharmaceutics, Hubei University of Technology, Wuhan, Hubei, 430068, China. jingfeng9930@163.com.

Veit Flockerzi (V)

Experimentelle und Klinische Pharmakologie und Toxikologie, Universität des Saarlandes, Homburg, 66421, Germany.

Ying Cao (Y)

School of Life Sciences and Technology, Tongji University, Shanghai, 200092, China.

Erhu Cao (E)

Department of Biochemistry, University of Utah School of Medicine, Salt Lake City, UT, 84112, USA. erhu.cao@biochem.utah.edu.

Xing-Zhen Chen (XZ)

National "111" Center for Cellular Regulation and Molecular Pharmaceutics, Hubei University of Technology, Wuhan, Hubei, 430068, China. xzchen@ualberta.ca.
Department of Physiology, Membrane Protein Disease Research Group, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, T6G 2H7, Canada. xzchen@ualberta.ca.

Classifications MeSH